5 AI-Powered Companies Transforming the Future of Fertility Care

Presently, one in every eight couples encounters challenges with infertility, and the available treatment options often come with a hefty price tag. In the United States, a single cycle of in vitro fertilization (IVF) costs approximately $12,000, with medication expenses driving the total up to $25,000. It's important to note that many patients typically require three to five cycles on average in order to achieve a successful pregnancy.

Developing countries also face significant infertility issues, affecting one in four couples worldwide. Overall, around 48.5 million couples globally struggle with infertility, and this condition is rapidly emerging as an epidemic.

Although IVF has been a widely used technique for over four decades, its outcomes remain unpredictable. Furthermore, access to fertility care remains dishearteningly low. In developed markets such as the United States, only 2% of individuals grappling with infertility have used IVF as a solution.

In his comment to Forbes Eran Eshed, the CEO of Fairtility, highlights the stagnation of data and artificial intelligence (AI) usage in influencing IVF outcomes, despite numerous advancements in biotechnology. Eshed emphasizes that while data science cannot resolve biological challenges, AI has the potential to revolutionize the IVF process by enhancing decision-making at every critical juncture. These advancements hold the promise of boosting embryologists' efficiency by up to 50% and increasing the chances of achieving a live birth by 4%.

Now, let's delve into the realm of fertility technology and explore five companies that are advancing the integration of AI to revolutionize the field.

ImVitro